In this webinar, Prof. Antonio Cuneo focused on exploring emerging therapies in CLL, discussing the clinical trials presented at ASH 2024, and considering the implications of minimal residual disease on patient quality of life.
In this webinar, Prof. Antonio Cuneo focused on exploring emerging therapies in CLL, discussing the clinical trials presented at ASH 2024, and considering the implications of minimal residual disease on patient quality of life.
Thank you! Your message has been sent.